Two kinds of combination therapy in the treatment of ischemic cerebral infarction cost-effectiveness analysis: cardiovascular and cerebrovascular diseases, as well as tumor diseases, which were more often seen in males than in females. CONCLUSION: The drugs used for elderly hospitalized patients were diverse in types. The expenses of injections showed the highest proportion in the total drug costs. Cerebrovascular and cardiovascular diseases and tumor diseases are the main diseases that threaten the health of aged people.
KEYWORDS: Elderly hospitalized patients; Drug use; Drug cost
With advances in science, healthcare, career development, and improvements in people’s living standards, the average human life expectancy has significantly increased. The health and quality of life of older persons have become a hot topic of social concern. According to relevant reports, the world’s elderly population (65 years and above) accounts for about 10% of the total population, and the growing trend shows that 23% of the total medical expenses are spent on elderly medical care. How to rationally use drugs to prevent and control age-related diseases and improve their quality of life is the responsibility of medical workers to provide accurate and effective drug treatment information. Cost-effectiveness analysis is based on the guiding ideology of achieving program objectives at the lowest cost. Achieving the objectives of the program with lower costs makes the program plan better. To evaluate the economic effects of the options, it is necessary to consider both costs and effects.
Yinxingdamo injection and Shuxuening injection in the treatment of ischemic cerebral infarction had efficiencies of 83.33% and 76.67%, respectively. Through cost-effectiveness analysis, the unit cost-effectiveness of the Yinxingdamo group was 12,928.75 yuan, which is 14,262.98 yuan less than the Shuxuening group. The Shuxuening group would need to spend an additional 1,334.23 yuan to increase the effect by one unit. Through sensitivity analysis, it was found that price changes within certain limits do not affect the analysis results, indicating that the analysis is credible and in line with the principles of pharmacoeconomics in drug selection. Ginkgo biloba extract and dipyridamole injection, as well as Shuxuening injection, showed a certain effect in the treatment of ischemic cerebral infarction. However, considering the principles of pharmacoeconomics, Ginkgo biloba extract and dipyridamole injection are effective and reliable, with reasonable costs and fewer adverse reactions, etc., and should be widely applied.
More articles related to topics: [omitted irrelevant content]